Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Pancreatic Neoplasms 2Gastrointestinal Neoplasms 2Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Melanoma 1Hepatoblastoma 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Specimen Handling 6X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Carboplatin 5Paclitaxel 4Nuclear Medicine Department, Hospital 4Biopsy 4selpercatinib 3Thiotepa 3Melphalan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Busulfan 3tazemetostat 2sargramostim 2olaparib 2larotrectinib 2etoposide phosphate 2erdafitinib 2ensartinib 2Vemurafenib 2Temozolomide 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × MLN 8237 × Gastrointestinal × Clear all
NCT01639911 2019-07-22

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

University of Illinois at Chicago

Phase 1 Completed
28 enrolled
BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Melanoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡